Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome plus posterior spinal nerve branch block in minimally invasive spinal surgery
ChiCTR2600116269Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: VAS pain scores. Started Jan 2026; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600116269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116269.